Liaoyuan Silver Eagle Pharmaceutical

Liaoyuan Silver Eagle Pharmaceutical is a Chinese pharmaceutical manufacturer focused on chemical active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and related manufacturing services. The company appears to operate primarily as a commercial-stage API producer rather than a drug discovery biotech, with capabilities spanning process development, pilot scale-up, and selected CMO work. Publicly available industry profiles indicate that it supplies multiple established small-molecule products, including metoclopramide hydrochloride, ambroxol hydrochloride, ethacridine lactate, sodium aminosalicylate, and metaraminol bitartrate. The company has been described as holding Chinese GMP qualifications and certain international regulatory or quality-related certifications and registrations, supporting export-oriented operations. Overall, it looks like a regional pharmaceutical manufacturing company serving finished-dose manufacturers and overseas buyers rather than a developer of a novel clinical pipeline.